ID

22098

Beschreibung

Gemcitabine for Marginal Zone Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00337259

Link

https://clinicaltrials.gov/show/NCT00337259

Stichworte

  1. 19.05.17 19.05.17 -
Hochgeladen am

19. Mai 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Non-Hodgkin's Lymphoma NCT00337259

Eligibility Non-Hodgkin's Lymphoma NCT00337259

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed marginal zone b-cell lymphoma
Beschreibung

Marginal Zone B-Cell Lymphoma

Datentyp

boolean

Alias
UMLS CUI [1]
C1367654
performance status (ecog) ≤3
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
age ≥ 18
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
at least one or more bidimensionally measurable lesion(s):
Beschreibung

Measurable lesion 2-Dimensional Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1705052
UMLS CUI [1,3]
C1265611
2 cm by conventional ct
Beschreibung

Lesion size X-Ray Computed Tomography

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0449453
UMLS CUI [1,2]
C0040405
1 cm by spiral ct
Beschreibung

Lesion size Spiral Computed Tomography

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0449453
UMLS CUI [1,2]
C0860888
skin lesion (photographs should be taken)
Beschreibung

Skin lesion Photograph

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0037284
UMLS CUI [1,2]
C0441468
measurable lesion by physical examination
Beschreibung

Measurable lesion Physical Examination

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0031809
laboratory values:
Beschreibung

Laboratory Results

Datentyp

boolean

Alias
UMLS CUI [1]
C1254595
cr < 2.0 mg% or ccr > 60 ml/min
Beschreibung

Creatinine measurement, serum | Creatinine clearance measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0373595
transaminase < 3 x upper normal value
Beschreibung

Transaminases

Datentyp

boolean

Alias
UMLS CUI [1]
C0002594
bilirubin < 2 mg%
Beschreibung

Serum total bilirubin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
anc > 1500/ul, platelet > 75,000/ul
Beschreibung

Absolute neutrophil count | Platelet Count measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
ann arbor stage iii or iv
Beschreibung

Ann Arbor lymphoma staging system

Datentyp

boolean

Alias
UMLS CUI [1]
C0432516
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
any other malignancies within the past 5 years except skin basal cell ca or cis of cervix
Beschreibung

Malignant Neoplasms | Basal cell carcinoma | Carcinoma in situ of uterine cervix

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0007117
UMLS CUI [3]
C0851140
serious comorbid diseases
Beschreibung

Comorbidity Serious

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205404
pregnancy or breast feeding
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147

Ähnliche Modelle

Eligibility Non-Hodgkin's Lymphoma NCT00337259

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Marginal Zone B-Cell Lymphoma
Item
histologically confirmed marginal zone b-cell lymphoma
boolean
C1367654 (UMLS CUI [1])
ECOG performance status
Item
performance status (ecog) ≤3
boolean
C1520224 (UMLS CUI [1])
Age
Item
age ≥ 18
boolean
C0001779 (UMLS CUI [1])
Measurable lesion 2-Dimensional Quantity
Item
at least one or more bidimensionally measurable lesion(s):
boolean
C1513041 (UMLS CUI [1,1])
C1705052 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Lesion size X-Ray Computed Tomography
Item
2 cm by conventional ct
boolean
C0449453 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
Lesion size Spiral Computed Tomography
Item
1 cm by spiral ct
boolean
C0449453 (UMLS CUI [1,1])
C0860888 (UMLS CUI [1,2])
Skin lesion Photograph
Item
skin lesion (photographs should be taken)
boolean
C0037284 (UMLS CUI [1,1])
C0441468 (UMLS CUI [1,2])
Measurable lesion Physical Examination
Item
measurable lesion by physical examination
boolean
C1513041 (UMLS CUI [1,1])
C0031809 (UMLS CUI [1,2])
Laboratory Results
Item
laboratory values:
boolean
C1254595 (UMLS CUI [1])
Creatinine measurement, serum | Creatinine clearance measurement
Item
cr < 2.0 mg% or ccr > 60 ml/min
boolean
C0201976 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
Transaminases
Item
transaminase < 3 x upper normal value
boolean
C0002594 (UMLS CUI [1])
Serum total bilirubin measurement
Item
bilirubin < 2 mg%
boolean
C1278039 (UMLS CUI [1])
Absolute neutrophil count | Platelet Count measurement
Item
anc > 1500/ul, platelet > 75,000/ul
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Ann Arbor lymphoma staging system
Item
ann arbor stage iii or iv
boolean
C0432516 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Malignant Neoplasms | Basal cell carcinoma | Carcinoma in situ of uterine cervix
Item
any other malignancies within the past 5 years except skin basal cell ca or cis of cervix
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
C0851140 (UMLS CUI [3])
Comorbidity Serious
Item
serious comorbid diseases
boolean
C0009488 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnancy or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video